Cargando…

Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast Cancer

IMPORTANCE: There is no proven test that can guide the optimal treatment, either endocrine therapy or chemotherapy, for estrogen receptor–positive breast cancer. OBJECTIVE: To investigate the associations of sperm-associated antigen 5 (SPAG5) transcript and SPAG5 protein expressions with treatment r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Fatah, Tarek M. A., Ball, Graham R., Thangavelu, Pulari U., Reid, Lynne E., McCart Reed, Amy E., Saunus, Jodi M., Duijf, Pascal H. G., Simpson, Peter T., Lakhani, Sunil R., Pongor, Lorinc, Győrffy, Balázs, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Caldas, Carlos, Ellis, Ian O., Chan, Stephen Y. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341179/ https://www.ncbi.nlm.nih.gov/pubmed/32633764 http://dx.doi.org/10.1001/jamanetworkopen.2020.9486

Ejemplares similares

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer
por: Menyhárt, Otília, et al.
Publicado: (2019)

In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion
por: Thangavelu, Pulari U., et al.
Publicado: (2016)

A snapshot of 3649 Web-based services published between 1994 and 2017 shows a decrease in availability after 2 years
por: Ősz, Ágnes, et al.
Publicado: (2017)

Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting
por: Pongor, Lőrinc S., et al.
Publicado: (2020)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation
por: Pongor, Lőrinc, et al.
Publicado: (2017)

A Molecular and Morphological Deep-Dive Into Metaplastic Breast Cancers
por: McCart Reed, Amy E, et al.
Publicado: (2019)

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020)

A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients
por: Pongor, Lőrinc, et al.
Publicado: (2015)

Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable Oncogenes
por: Menyhart, Otília, et al.
Publicado: (2019)

An Update on the Molecular Pathology of Metaplastic Breast Cancer
por: McCart Reed, Amy E, et al.
Publicado: (2021)

NDRG1 in Cancer: A Suppressor, Promoter, or Both?
por: Joshi, Vaibhavi, et al.
Publicado: (2022)

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020)

An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes
por: Győrffy, Balázs, et al.
Publicado: (2018)

Overexpression of the E2F target gene CENPI promotes chromosome instability and predicts poor prognosis in estrogen receptor-positive breast cancer
por: Thangavelu, Pulari U., et al.
Publicado: (2017)

Different mutations in SARS-CoV-2 associate with severe and mild outcome
por: Nagy, Ádám, et al.
Publicado: (2021)

Invasive lobular carcinoma of the breast: the increasing importance of this special subtype
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics
por: Reed, Amy E McCart, et al.
Publicado: (2015)

Fast and Sensitive Alignment of Microbial Whole Genome Sequencing Reads to Large Sequence Datasets on a Desktop PC: Application to Metagenomic Datasets and Pathogen Identification
por: Pongor, Lőrinc S., et al.
Publicado: (2014)

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
por: Momeny, Majid, et al.
Publicado: (2015)

Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
por: Croft, Priyakshi Kalita-de, et al.
Publicado: (2021)

Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer
por: Kutasovic, Jamie R., et al.
Publicado: (2020)

Toothache of Horses
por: McCart, T. S.
Publicado: (1887)

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2
por: Abdel-Fatah, Tarek M.A, et al.
Publicado: (2017)

Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2022)

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study
por: Kutasovic, Jamie R, et al.
Publicado: (2018)

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2022)

Molecular Aspects of Breast Cancer Metastasis to the Brain
por: Saunus, Jodi M., et al.
Publicado: (2011)

Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer
por: Pálinkás, Hajnalka Laura, et al.
Publicado: (2022)

TP53 mutation hits energy metabolism and increases glycolysis in breast cancer
por: Harami-Papp, Hajnalka, et al.
Publicado: (2016)

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
por: Bellanger, Aurélie, et al.
Publicado: (2021)

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
por: Bessette, Darrell C., et al.
Publicado: (2015)

Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950
por: McCart Reed, Amy E., et al.
Publicado: (2021)

The Genomic Landscape of Lobular Breast Cancer
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related
por: Kutasovic, Jamie R., et al.
Publicado: (2020)

SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer
por: Burgess, Joshua T., et al.
Publicado: (2016)

LobSig is a multigene predictor of outcome in invasive lobular carcinoma
por: McCart Reed, Amy E., et al.
Publicado: (2019)

Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms
por: Feng, Yufan, et al.
Publicado: (2023)

A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results
por: Ligeti, Balázs, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oac7n5euced8hoofmnv77lbnt2